PURPOSE: Currently, no tests are available to monitor and predict severity and outcome of dengue. To find potential markers that predict dengue severity, the present study validated the serum level of three acute-phase proteins α-1 antitrypsin, ceruloplasmin and ferritin in a pool of severe dengue cases compared to non-severe forms and other febrile illness controls. METHODS: A total of 96 patients were divided into two equal groups with group 'A' comprising dengue-infected cases and group 'B' with other febrile illness cases negative for dengue. Out of 48 dengue-infected cases, 13 had severe dengue and the remaining 35 were classified as non-severe dengue. Immunoassays were performed to evaluate the serum levels of acute-phase proteins both on the day of admission and on the day of defervescence. The efficiency of individual proteins in predicting the disease severity was assessed using receiver operating characteristic curve. RESULTS: The study did not find any significant difference in the levels of α-1 antitrypsin between the clinical groups. A significant increase in the levels of ceruloplasmin around defervescence in severe cases compared to non-severe and other febrile controls was observed and this is the first report describing the potential association of ceruloplasmin and dengue severity. Interestingly, a steady increase in the level of serum ferritin was recorded throughout the course of illness. Among all the three proteins, the elevated ferritin level could predict the disease severity with highest sensitivity and specificity of 76.9 and 83.3 %, respectively, on the day of admission and the same was found to be 90 and 91.6 % around defervescence. CONCLUSION: On the basis of this diagnostic efficiency, we propose that ferritin may serve as a potential biomarker for an early prediction of disease severity.
PURPOSE: Currently, no tests are available to monitor and predict severity and outcome of dengue. To find potential markers that predict dengue severity, the present study validated the serum level of three acute-phase proteins α-1 antitrypsin, ceruloplasmin and ferritin in a pool of severe dengue cases compared to non-severe forms and other febrile illness controls. METHODS: A total of 96 patients were divided into two equal groups with group 'A' comprising dengue-infected cases and group 'B' with other febrile illness cases negative for dengue. Out of 48 dengue-infected cases, 13 had severe dengue and the remaining 35 were classified as non-severe dengue. Immunoassays were performed to evaluate the serum levels of acute-phase proteins both on the day of admission and on the day of defervescence. The efficiency of individual proteins in predicting the disease severity was assessed using receiver operating characteristic curve. RESULTS: The study did not find any significant difference in the levels of α-1 antitrypsin between the clinical groups. A significant increase in the levels of ceruloplasmin around defervescence in severe cases compared to non-severe and other febrile controls was observed and this is the first report describing the potential association of ceruloplasmin and dengue severity. Interestingly, a steady increase in the level of serum ferritin was recorded throughout the course of illness. Among all the three proteins, the elevated ferritin level could predict the disease severity with highest sensitivity and specificity of 76.9 and 83.3 %, respectively, on the day of admission and the same was found to be 90 and 91.6 % around defervescence. CONCLUSION: On the basis of this diagnostic efficiency, we propose that ferritin may serve as a potential biomarker for an early prediction of disease severity.
Authors: D Fuchs; R Zangerle; E Artner-Dworzak; G Weiss; P Fritsch; G P Tilz; M P Dierich; H Wachter Journal: Eur J Haematol Date: 1993-02 Impact factor: 2.997
Authors: Martijn D de Kruif; Tatty E Setiati; Albertus T A Mairuhu; Penelopie Koraka; Hella A Aberson; C Arnold Spek; Albert D M E Osterhaus; Pieter H Reitsma; Dees P M Brandjes; Augustinus Soemantri; Eric C M van Gorp Journal: PLoS Negl Trop Dis Date: 2008-04-09
Authors: Meta Michels; Quirijn de Mast; Mihai G Netea; Leo A Joosten; Charles A Dinarello; Pandji I F Rudiman; Sylvia Sinarta; Rudi Wisaksana; Bachti Alisjahbana; André J A M van der Ven Journal: Clin Vaccine Immunol Date: 2015-04-15
Authors: Julia L Finkelstein; Susannah Colt; Alexander J Layden; Jesse T Krisher; Anna M Stewart-Ibarra; Mark Polhemus; Efraín Beltrán-Ayala; Julia M Tedesco; Washington B Cárdenas; Timothy Endy; Saurabh Mehta Journal: J Infect Dis Date: 2020-01-01 Impact factor: 5.226
Authors: Esther M Ellis; Tyler M Sharp; Janice Pérez-Padilla; Liza González; B Katherine Poole-Smith; Emmaculate Lebo; Charlotte Baker; Mark J Delorey; Brenda Torres-Velasquez; Eduardo Ochoa; Brenda Rivera-Garcia; Hector Díaz-Pinto; Luis Clavell; Anabel Puig-Ramos; Gritta E Janka; Kay M Tomashek Journal: PLoS Negl Trop Dis Date: 2016-08-24